Car, I.; Dittmann, A.; Vasieva, O.; Bočkor, L.; Grbčić, P.; Piteša, N.; Klobučar, M.; Kraljević Pavelić, S.; Sedić, M.
Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. Int. J. Mol. Sci. 2023, 24, 12906.
https://doi.org/10.3390/ijms241612906
AMA Style
Car I, Dittmann A, Vasieva O, Bočkor L, Grbčić P, Piteša N, Klobučar M, Kraljević Pavelić S, Sedić M.
Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. International Journal of Molecular Sciences. 2023; 24(16):12906.
https://doi.org/10.3390/ijms241612906
Chicago/Turabian Style
Car, Iris, Antje Dittmann, Olga Vasieva, Luka Bočkor, Petra Grbčić, Nikolina Piteša, Marko Klobučar, Sandra Kraljević Pavelić, and Mirela Sedić.
2023. "Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro" International Journal of Molecular Sciences 24, no. 16: 12906.
https://doi.org/10.3390/ijms241612906
APA Style
Car, I., Dittmann, A., Vasieva, O., Bočkor, L., Grbčić, P., Piteša, N., Klobučar, M., Kraljević Pavelić, S., & Sedić, M.
(2023). Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. International Journal of Molecular Sciences, 24(16), 12906.
https://doi.org/10.3390/ijms241612906